Kentucky
General Assembly

Search

House Bill 95

Actions | Amendments

Last Action	03/22/21: signed by Governor (Acts Ch. 75)
Title	AN ACT relating to prescription insulin.
Bill Documents	Acts Chapter 75 Current/Final Introduced
Fiscal Impact Statements	Health Mandate Additional Fiscal Impact Statements Exist
Bill Request Number	831
Sponsors	D. Bentley, P. Minter, K. Banta, J. Blanton, T. Bojanowski, J. Branscum, J. Bray, R. Bridges, G. Brown Jr., T. Burch, J. Calloway, M. Cantrell, J. Decker, J. Donohue, M. Dossett, R. Dotson, J. DuPlessis, D. Elliott, J. Fischer, D. Fister, P. Flannery, K. Flood, D. Frazier, C. Fugate, A. Gentry, J. Gooch Jr., D. Graham, D. Hale, M. Hart, A. Hatton, S. Heavrin, T. Huff, J. Jenkins, DJ Johnson, K. King, N. Kirk-McCormick, N. Kulkarni, W. Lawrence, S. Lewis, M. Marzian, C. Massey, B. McCool, R. Meeks, M. Meredith, C. Miller, R. Palumbo, P. Pratt, M. Prunty, J. Raymond, B. Reed, S. Riley, R. Roberts, S. Rudy, S. Santoro, A. Scott, S. Sharp, S. Sheldon, C. Stevenson, P. Stevenson, A. Tackett Laferty, N. Tate, W. Thomas, J. Tipton, K. Upchurch, R. Webber, B. Wesley, S. Westrom, B. Wheatley, L. Willner
Summary of Original Version	Amend KRS 304-17A.148 to cap the cost-sharing requirements for prescription insulin at $30 per 30 day supply; amend KRS 18A.225 to require the Kentucky Employee Health Plan to comply; EFFECTIVE January 1, 2022.
Index Headings of Original Version	Health Benefit Mandate - Prescription insulin drugs, cost sharing, cap Diseases - Diabetes, prescription insulin drugs, cost sharing, cap Drugs and Medicines - Prescription insulin drugs, cost sharing, cap Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2022 Insurance, Health - Prescription insulin drugs, cost sharing, cap
Jump to Proposed Amendments	House Committee Substitute 1 with Fiscal Impact Statements Senate Committee Substitute 1 with Fiscal Impact Statements Senate Floor Amendment 1 Senate Floor Amendment 2 Senate Floor Amendment 3
Votes	Vote History

Actions

Top | Amendments

11/19/20	Prefiled by the sponsor(s).
01/05/21	introduced in House to Committee on Committees (H)
02/02/21	to Health & Family Services (H)
02/10/21	posted in committee
02/11/21	reported favorably, 1st reading, to Calendar with Committee Substitute
02/22/21	2nd reading, to Rules posted for passage in the Regular Orders of the Day for Tuesday, February 23, 2021
02/23/21	3rd reading, passed 95-0 with Committee Substitute
02/24/21	received in Senate to Committee on Committees (S)
02/26/21	to Banking & Insurance (S)
03/02/21	reported favorably, 1st reading, to Consent Calendar with Committee Substitute (1) floor amendment (1) filed to Committee Substitute, floor amendment (2) filed to bill
03/03/21	2nd reading, to Rules posted for passage in the Regular Orders of the Day for Friday, March 5, 2021
03/04/21	floor amendment (3) filed to Committee Substitute
03/05/21	3rd reading floor amendment (1) withdrawn passed 35-0 with Committee Substitute and floor amendments (3) and (2-title)
03/11/21	received in House to Rules (H)
03/12/21	taken from Rules posted for passage for concurrence in Senate Committee Substitute and floor amendments (3) and (2-title) House refused to concur in Senate Committee Substitute, floor amendments (3) and (2-title)
03/15/21	received in Senate to Rules (S) posted for passage for receding from Senate Committee Substitute, and floor amendments (3) and (2-title) for Tuesday, March 16, 2021
03/16/21	Senate receded from Committee Substitute (1) and floor amendments (2-title) and (3) Bill passed 36-0 received in House enrolled, signed by Speaker of the House enrolled, signed by President of the Senate delivered to Governor
03/22/21	signed by Governor (Acts Ch. 75)

Proposed Amendments

Top | Actions

Amendment	House Committee Substitute 1
Fiscal Impact Statement	Health Mandate to House Committee Substitute 1
Summary	Retain original provisions; delete provision prohibiting an insurer with a cost-sharing requirment of less than $30 for a 30 day supply of prescription inuslin on the effective date of this Act from increasing that cost-sharing requirement; define "cost sharing."
Index Headings	Diseases - Prescription insulin drugs, cost sharing, cap Drugs and Medicines - Prescription insulin drugs, cost sharing, cap Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2022 Health Benefit Mandate - Prescription insulin drugs, cost sharing, cap Insurance, Health - Prescription insulin drugs, cost sharing, cap

Amendment	Senate Committee Substitute 1
Fiscal Impact Statement	Health Mandate to Senate Committee Substitute 1
Summary	Retain original provisions; increase cap on cost-sharing requirements for prescription insulin to $35 for a 30 day supply; EFFECTIVE January 1, 2022.
Index Headings	Diseases - Diabetes, prescription insulin drugs, cost sharing, cap Drugs and Medicines - Prescription insulin drugs, cost sharing, cap Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2022 Insurance, Health - Prescription insulin drugs, cost sharing, cap Health Benefit Mandate - Prescription insulin drugs, cost sharing, cap

Amendment	Senate Floor Amendment 1
Sponsor	J. Carpenter
Summary	Delete delayed effective date and replace with emergency clause. EMERGENCY.
Index Headings	Effective Dates, Emergency - Prescription insulin drugs, cost sharing, cap

Amendment	Senate Floor Amendment 2
Sponsor	J. Carpenter
Summary	Make title amendment.
Index Headings	Title Amendments - HB 95/GA

Amendment	Senate Floor Amendment 3
Sponsor	J. Carpenter
Summary	Provide that section on diabetes coverage is subject to federal law and regulations; delete delayed effective date and replace with emergency clause. EMERGENCY.
Index Headings	Federal Laws and Regulations - Health benefit plans, diabetes, coverage Effective Dates, Emergency - Prescription insulin drugs, cost sharing, cap

Last updated: 5/18/2021 11:08 AM (EDT)
To receive notice when the record is updated follow @LRCTweetBot. @LRCTweetBot